TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

Primary central nervous system lymphoma (PCNSL) is an aggressive variant of diffuse large B-cell lymphoma (DLBCL) confined to the CNS. TP53 mutations (MUT-TP53) were investigated in the context of MIR34A/B/C- and DAPK promoter methylation status, and associated with clinical outcomes in PCNSL patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Neuropathol Commun
Autors principals: Munch-Petersen, Helga D., Asmar, Fazila, Dimopoulos, Konstantinos, Areškevičiūtė, Aušrinė, Brown, Peter, Girkov, Mia Seremet, Pedersen, Anja, Sjö, Lene D., Heegaard, Steffen, Broholm, Helle, Kristensen, Lasse S., Ralfkiaer, Elisabeth, Grønbæk, Kirsten
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840983/
https://ncbi.nlm.nih.gov/pubmed/27101868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-016-0307-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars